ALURD (Allurion Technologies) Stock Based Compensation: $2.89 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALURD Allurion Technologies Inc ALURD
11 GF Score
Price $4.30
GF Value $10.42
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Allurion Technologies Stock Based Compensation?

Allurion Technologies ALURD 11 Stock Based Compensation is $2.89 Mil as of Mar. 2026. GuruFocus rates ALURD with a GF Score™ of 11/100 and a GF Value™ of $10.42 (Possible Value Trap). The stock has 4 warning signs investors should review.

Allurion Technologies's Stock Based Compensation for the three months ended in Mar. 2026 was $0.64 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $2.89 Mil.

Allurion Technologies Stock Based Compensation Related Terms

Allurion Technologies Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Allurion Technologies's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allurion Technologies Stock Based Compensation Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
0.31 0.44 8.36 3.06 3.15

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 1.02 0.53 0.70 0.64
ALURD
11GF Score
Allurion Technologies Inc ALURD
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allurion Technologies Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.89 Mil.

What does a Stock Based Compensation of $2.89 Mil mean?
Allurion Technologies (ALURD) has a Stock Based Compensation of $2.89 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Allurion Technologies and its competitors.
Is Allurion Technologies' Stock Based Compensation too high?
Allurion Technologies' current Stock Based Compensation is $2.89 Mil. Overall, Allurion Technologies has a GF Score™ of 11/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Allurion Technologies' Stock Based Compensation compare to ITOC and USAQ?
Allurion Technologies' Stock Based Compensation of $2.89 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Allurion Technologies and its competitors. Allurion Technologies's current Stock Based Compensation is $2.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allurion Technologies stock overvalued right now?
Based on GuruFocus' analysis, Allurion Technologies (ALURD) is currently considered Possible Value Trap. The stock's GF Value™ is $10.42, compared to a current price of $4.30 — trading 58.7% below its estimated fair value. The current Stock Based Compensation is $2.89 Mil. Allurion Technologies' overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Allurion Technologies (ALURD), the current Stock Based Compensation is $2.89 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allurion Technologies (ALURD) Overvalued in 2026?

Based on GuruFocus' analysis, Allurion Technologies stock appears to be undervalued. The current stock price of $4.30 is trading 58.7% below its estimated GF Value™ of $10.42. GuruFocus considers Allurion Technologies to be Possible Value Trap.

Key valuation signals for ALURD:

  • Stock Based Compensation: $2.89 Mil
  • GF Value™: $10.42 vs. price of $4.30 (58.7% below fair value)
  • GF Score™: 11/100 with 4 warning signs

No single metric tells the full story. See the ALURD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allurion Technologies Business Description

Address 11 Huron Drive, Natick, MA, USA, 01760
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
11GF Score

Get the complete analysis for ALURD

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.30
Price
$10.42
GF Value